SG Americas Securities »

Enliven Therapeutics shares owned by SG Americas Securities

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by SG Americas Securities from 13F filings

Historical chart of SG Americas Securities investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by SG Americas Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by SG Americas Securities

Quarter filed Position value Share count Share price at filing
2023-12-31 $187k 14k 13.85
2023-09-30 $157k 12k 13.70